Bank of The West Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Bank of The West cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 15.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 32,545 shares of the healthcare conglomerate’s stock after selling 5,992 shares during the quarter. UnitedHealth Group makes up approximately 1.3% of Bank of The West’s investment portfolio, making the stock its 16th largest holding. Bank of The West’s holdings in UnitedHealth Group were worth $13,033,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. First Manhattan Co. raised its stake in UnitedHealth Group by 19.7% in the 1st quarter. First Manhattan Co. now owns 1,482,677 shares of the healthcare conglomerate’s stock valued at $551,661,000 after purchasing an additional 243,529 shares during the last quarter. GWM Advisors LLC boosted its holdings in UnitedHealth Group by 8.3% during the 2nd quarter. GWM Advisors LLC now owns 31,240 shares of the healthcare conglomerate’s stock valued at $12,510,000 after acquiring an additional 2,397 shares during the period. Veritas Asset Management LLP boosted its holdings in UnitedHealth Group by 0.4% during the 1st quarter. Veritas Asset Management LLP now owns 2,572,968 shares of the healthcare conglomerate’s stock valued at $957,324,000 after acquiring an additional 10,713 shares during the period. Seven Springs Wealth Group LLC boosted its stake in shares of UnitedHealth Group by 58.6% in the 2nd quarter. Seven Springs Wealth Group LLC now owns 2,544 shares of the healthcare conglomerate’s stock valued at $1,019,000 after buying an additional 940 shares during the period. Finally, Reliant Investment Management LLC raised its position in shares of UnitedHealth Group by 2.0% during the 1st quarter. Reliant Investment Management LLC now owns 13,324 shares of the healthcare conglomerate’s stock worth $4,957,000 after acquiring an additional 255 shares in the last quarter. Hedge funds and other institutional investors own 86.21% of the company’s stock.

In related news, Director Richard T. Burke sold 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 20th. The shares were sold at an average price of $414.31, for a total value of $3,314,480.00. Following the completion of the transaction, the director now owns 154,403 shares in the company, valued at approximately $63,970,706.93. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Stephen J. Hemsley sold 60,000 shares of the company’s stock in a transaction on Friday, July 16th. The shares were sold at an average price of $420.62, for a total transaction of $25,237,200.00. Following the sale, the director now owns 941,560 shares of the company’s stock, valued at approximately $396,038,967.20. The disclosure for this sale can be found here. Insiders have sold 98,938 shares of company stock worth $41,349,429 over the last ninety days. Company insiders own 0.55% of the company’s stock.

A number of analysts recently weighed in on UNH shares. Barclays lifted their price target on UnitedHealth Group from $435.00 to $465.00 and gave the company an “overweight” rating in a research note on Friday, July 16th. Credit Suisse Group upped their target price on UnitedHealth Group from $430.00 to $462.00 and gave the company an “outperform” rating in a research note on Friday, July 16th. Raymond James upped their price target on UnitedHealth Group from $435.00 to $515.00 and gave the stock a “strong-buy” rating in a research note on Friday, July 16th. Oppenheimer reissued a “buy” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Thursday, July 15th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $418.00 to $421.00 and gave the stock a “buy” rating in a report on Tuesday, July 13th. Three equities research analysts have rated the stock with a hold rating, twenty have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $444.04.

Shares of UnitedHealth Group stock traded down $3.13 during trading on Monday, reaching $417.03. The company’s stock had a trading volume of 14,987 shares, compared to its average volume of 2,972,667. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.77 and a current ratio of 0.77. The business’s fifty day moving average price is $416.57 and its 200-day moving average price is $400.07. The firm has a market cap of $393.22 billion, a price-to-earnings ratio of 27.75, a price-to-earnings-growth ratio of 1.62 and a beta of 0.77. UnitedHealth Group Incorporated has a one year low of $289.64 and a one year high of $431.36.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Wednesday, July 14th. The healthcare conglomerate reported $4.70 earnings per share for the quarter, topping analysts’ consensus estimates of $4.43 by $0.27. UnitedHealth Group had a return on equity of 22.15% and a net margin of 5.33%. The business had revenue of $71.32 billion for the quarter, compared to the consensus estimate of $69.51 billion. During the same period last year, the business earned $7.12 earnings per share. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 18.74 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 21st. Shareholders of record on Monday, September 13th will be issued a dividend of $1.45 per share. This represents a $5.80 dividend on an annualized basis and a yield of 1.39%. The ex-dividend date of this dividend is Friday, September 10th. UnitedHealth Group’s payout ratio is 34.36%.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Further Reading: Investing in Blue-Chip Stocks

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.